Host: W. Brian Gibler, MD, FACEP, FACC, FAHA

Host: Natalie Kreitzer, MD, MS

Host: Adrian R. Parry-Jones, FRCP, PhD

Host: David Seiffge, MD

This enduring activity was originally presented as a satellite symposium which was held during the 9th European Stroke Organisation Conference (ESOC) in Munich, Germany, in May 2023.

As the utilization of direct oral anticoagulants (DOACs) increases, there is a parallel increase in major bleeding events, especially intracranial hemorrhages (ICH), requiring hospitalization. Clinicians are not recognizing or distinguishing major from minor bleeding or appropriately employing emergent options to manage major bleeding. Recent solutions for DOAC-related life-threatening bleeding are under-recognized and under-utilized solutions for patients with these life-threatening emergencies. Recently, nationally recognized guidelines have provided clear direction for managing these major bleeding events. As data emerges regarding new approaches to therapy, clinicians need to be aware of these new and effective approaches and assess the benefits and risks associated with each of these approaches. This program focuses on managing ICHs, addresses patient treatment approaches, and distills essential information for everyday clinical practice.